Pattern Bioscience Names Carey-Ann Burnham CEO as Founder Transitions to CTO

Pattern Bioscience, a leader in diagnostic technology for bacterial infections, has appointed Carey-Ann Burnham, PhD, as Chief Executive Officer. Former CEO and founder Nick Arab will become Chief Technology Officer to focus on advancing the company's unique single-cell microbiology technology. The company is transitioning from the research phase to clinical validation of its innovative culture-free microbial identification and susceptibility testing platform, which aims to deliver results in hours instead of days. Dr. Burnham, with extensive experience in microbiology and clinical operations, is positioned to guide the company during this pivotal stage. Pattern's groundbreaking technology plans to address critical challenges in diagnosing bacterial infections and combating antimicrobial resistance. This leadership change is crucial as the company moves towards regulatory submission and eventual market launch. The transition is supported by Illumina Ventures, reflecting a strategic push to redefine rapid diagnostic solutions in healthcare.